In the latest session, Sotera Health Co (NASDAQ: SHC) closed at $11.38 down -2.74% from its previous closing price of $11.70. In other words, the price has decreased by -$0.32 from its previous closing price. On the day, 1403000 shares were traded.
Ratios:
For a deeper understanding of Sotera Health Co’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 5.24 whereas as Long-Term Debt/Eq ratio is at 5.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 25, 2024, Upgraded its rating to Buy and sets its target price to $15.50 from $15 previously.
KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on June 26, 2023, while the target price for the stock was maintained at $24.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’24 when WARBURG PINCUS & CO. sold 16,594,363 shares for $14.31 per share. The transaction valued at 237,423,849 led to the insider holds 88,822,952 shares of the business.
WARBURG PINCUS & CO. sold 16,594,363 shares of SHC for $237,423,849 on Mar 04 ’24. The Director now owns 88,822,952 shares after completing the transaction at $14.31 per share. On Mar 04 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 11,062,908 shares for $14.31 each. As a result, the insider received 158,282,556 and left with 59,215,301 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 3.22B and an Enterprise Value of 5.25B. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 63.33, and their Forward P/E ratio for the next fiscal year is 13.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.28. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.07 while its Price-to-Book (P/B) ratio in mrq is 7.25. Its current Enterprise Value per Revenue stands at 5.00 whereas that against EBITDA is 12.90.
Stock Price History:
Over the past 52 weeks, SHC has reached a high of $19.40, while it has fallen to a 52-week low of $10.74. The 50-Day Moving Average of the stock is 14.56, while the 200-Day Moving Average is calculated to be 15.38.
Shares Statistics:
For the past three months, SHC has traded an average of 1.73M shares per day and 2.85M over the past ten days. A total of 282.83M shares are outstanding, with a floating share count of 126.48M. Insiders hold about 55.28% of the company’s shares, while institutions hold 28.63% stake in the company. Shares short for SHC as of Mar 15, 2024 were 11.58M with a Short Ratio of 6.68, compared to 12.02M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.10% and a Short% of Float of 11.61%.
Earnings Estimates
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.13 for the current quarter, with a high estimate of $0.15 and a low estimate of $0.11, while EPS last year was $0.13. The consensus estimate for the next quarter is $0.18, with high estimates of $0.2 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.72 and $0.7 for the fiscal current year, implying an average EPS of $0.71. EPS for the following year is $0.85, with 7 analysts recommending between $0.93 and $0.82.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $244.56M this quarter.It ranges from a high estimate of $255M to a low estimate of $234.8M. As of the current estimate, Sotera Health Co’s year-ago sales were $220.59M, an estimated increase of 10.90% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $276.65M, an increase of 8.40% less than the figure of $10.90% in the same quarter last year. There is a high estimate of $286.9M for the next quarter, whereas the lowest estimate is $265.71M.
A total of 7 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.11B, while the lowest revenue estimate was $1.09B, resulting in an average revenue estimate of $1.1B. In the same quarter a year ago, actual revenue was $1.05B, up 4.80% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.19B and the low estimate is $1.17B. The average revenue growth estimate for next year is up 7.10% from the average revenue estimate for this year.
